139 search results for “titel therapy” in the Student website
-
Peter ten DijkeFaculteit Geneeskunde
p.ten_dijke@lumc.nl | +31 71 526 9270
-
James HardwickFaculteit Geneeskunde
j.c.h.hardwick@lumc.nl | +31 71 526 5364
-
Manfred WuhrerFaculteit Geneeskunde
m.wuhrer@lumc.nl | +31 71 526 9111
-
Jerry BraunFaculteit Geneeskunde
j.braun@lumc.nl | +31 71 526 4022
-
Maarten VermeerFaculteit Geneeskunde
m.h.vermeer@lumc.nl | +31 71 526 1952
-
Koos van der HoevenFaculteit Geneeskunde
j.j.m.van.der.hoeven@lumc.nl | +31 71 526 9111
-
Gregorius LuytenFaculteit Geneeskunde
g.p.m.luyten@lumc.nl | +31 71 526 6674
-
Henri VersteegFaculteit Geneeskunde
h.h.versteeg@lumc.nl | +31 71 526 3872
-
Bart van HoekFaculteit Geneeskunde
b.van_hoek@lumc.nl | 071 5269111
-
Corrie MarijnenFaculteit Geneeskunde
c.a.m.marijnen@lumc.nl | +31 71 526 5539
-
Johanna MeijerFaculteit Geneeskunde
j.h.meijer@lumc.nl | +31 71 526 9760
-
Fijs van LeeuwenFaculteit Geneeskunde
f.w.b.van_leeuwen@lumc.nl | +31 71 526 9111
-
Hein PutterFaculteit Geneeskunde
h.putter@lumc.nl | 071 5279705
-
From research to practice: Leiden researchers awarded European grant
Various Leiden researchers have been awarded a European grant to explore the commercial or societal potential of previous research.
-
Unlocking the secrets of DNA repair: Sarah’s curiosity might lead to new cancer treatments
How do cells repair their damaged DNA—and what happens when that process is hindered and cancer arises? Sarah Moser has taken a closer look during her PhD, uncovering surprising insights that could help improve future cancer treatments.
-
Sibel Bahtiri is one of the new Faces of Science: ‘I want to show how we’re finding alternatives to animal testing’
PhD candidate Sibel Bahtiri is one of the new Faces of Science. In videos and blogs, she will show what life is like as a young researcher.
-
One million euros grant for smart antibiotic combinations – tackling resistant infections and antimicrobial resistance
Optimised antibiotic combinations can combat bacteria more effectively while also slowing the development of resistance. Scientists from five European countries are joining forces to identify such combinations and provide tools for others to do the same. The project is led by Professor Coen van Hasselt…
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
- Consent is key
-
Chemistry as the key to medical innovation
Is it a coincidence that three chemists from the same department have each independently received a ZonMw grant? 'No,' the researchers agree in unison. 'The role of chemistry in medical biology is becoming increasingly important, and we’ve worked hard to make this happen.'
-
New potential cancer drugs and where to find them
Cancer research generates massive amounts of data, but traditional tools often fail to fully harness their potential. How can we unlock this data to provide better treatments for cancer patients? PhD candidate Marina Gorostiola González explored this by using advanced data analysis techniques to guide…
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
Energy as a weak spot: a new approach to tackle aggressive breast cancer?
Could we stop cancer cells by cutting off their energy supply? That’s what Dione Blok, a bachelor’s student in Bio-Pharmaceutical Sciences, aimed to find out during her thesis research. She investigated a compound that affects the tumour cells’ energy metabolism. ‘Hopefully, these insights will provide…
-
Leiden technology research receives funding from NWO and businesses
A CT scanner to treat eye cancer, energy-efficient software for the future and a test to identify male chick eggs. Three projects by researchers from Leiden University are to receive funding from research funder NWO’s Open Technology programme, to which the business sector also contributes.
-
Promising new technique to treat cancer receives NWO grant
Biological chemist Nathaniel Martin and his team received an NWO grant to examine how blocking a specific enzyme in our body, NNMT, could be helpful in the treatment of some cancers. Trials with mice have been promising, and together with the Netherlands Cancer Institute, Martin wants to take the next…
-
King of Sweden visits Leiden University
Collaborating in drug discovery and health research was the goal of a visit to the Leiden Bio Science Park on 14 May by a Swedish delegation including His Majesty King Carl XVI Gustav of Sweden. The delegation visited Leiden University’s Faculty of Science.
- Blue Monday? Join the online Body & Mind Vital programme for free
-
Ingrid MeulenbeltFaculteit Geneeskunde
i.meulenbelt@lumc.nl | +31 71 526 9734
-
Thijs van OschFaculteit Geneeskunde
m.j.p.van_osch@lumc.nl | +31 71 526 9111
-
Olaf DekkersFaculteit Geneeskunde
o.m.dekkers@lumc.nl | +31 71 526 9111
-
Peter DevileeFaculteit Geneeskunde
p.devilee@lumc.nl | +31 71 526 9510
-
Saskia le CessieFaculteit Geneeskunde
s.le_cessie@lumc.nl | +31 71 527 2124
-
Jacques van DongenFaculteit Geneeskunde
j.j.m.van_dongen@lumc.nl |
-
Rob TollenaarFaculteit Geneeskunde
r.a.e.m.tollenaar@lumc.nl | +31 71 526 4910
-
Adam CohenFaculteit Geneeskunde
ac@chdr.nl | 071 5269111
-
Ferry OssendorpFaculteit Geneeskunde
f.a.ossendorp@lumc.nl | +31 71 526 3800
-
Christi van AsperenFaculteit Geneeskunde
c.j.van_asperen@lumc.nl | +31 71 526 6090
-
Carien CreutzbergFaculteit Geneeskunde
c.l.creutzberg@lumc.nl | +31 71 526 5120
-
Jelle GoemanFaculteit Geneeskunde
j.j.goeman@lumc.nl | +31 71 526 9700
-
Sjoerd van der BurgFaculteit Geneeskunde
s.h.van_der_burg@lumc.nl | +31 71 526 1180
-
Marcel TijstermanFaculteit Geneeskunde
m.tijsterman@lumc.nl | +31 71 526 9111
-
Pieter HiemstraFaculteit Geneeskunde
p.s.hiemstra@lumc.nl | 071 5269111
-
Maartje SchoorlSocial & Behavioural Sciences
s.m.d.schoorl@umail.leidenuniv.nl | 071 5272727
-
Henk-Jan GuchelaarFaculty of Science
h.j.guchelaar@lumc.nl | +31 71 526 2790
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
3D-printed mini-tumours: a leap forward in improving cancer immunotherapy
Leiden researchers have developed a groundbreaking model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within an environment that closely mimics human tissue. They have also developed a method to monitor real-time interactions of these mini-tumours with immune cells during…
-
Two young researchers win Krijn Rietveld Award for innovative research on blood donation and colorectal cancer
One used 3D cell models to study colorectal cancer, while the other used machine learning for more efficient blood donation. For these achievements, Marieke Vinkenoog and Simon Christian Hansmann were awarded the Krijn Rietveld Memorial Innovation Award on Tuesday 2 September.
-
Lowlands as lab: virtual trips in the name of science
While tens of thousands of visitors dance to deafening music, a team of Leiden psychologists are trying to collect data for their research at Lowlands. How do festivalgoers experience a virtual trip? And what role do factors such as too little sleep and whether they have experience with psychedelics…
-
Iprotics Wins the Venture Challenge Spring 2022
The winner of the 2022 Spring edition of the NWO Venture Challenge was announced during the Dutch Biotech Event. The innovative startup Iprotics has developed specific proteasome inhibitors that potentially treat multiple myeloma (MM) without the side-effects known from traditional proteasome inhibi…
-
Hanno PijlFaculteit Geneeskunde
h.pijl@lumc.nl | +31 71 526 3571